An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article
| Image |  |
|---|---|
| Description | scientific article published on July 2017 |
| Author/s |
author: Hou-Wen Lin |
| Publication date | July 1, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |